EXELIXIS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 21.06 USD | +0.72% |
|
-0.99% | -12.21% |
| May. 20 | Exelixis Settles Cabometyx Patent Litigation with Cipla | MT |
| May. 14 | Transcript : Exelixis, Inc. Presents at 2024 RBC Capital Markets Global Healthcare Conference, May-14-2024 02:35 PM |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Neutral | Neutral |
| Resistance | 22.15 | 24.13 | 23.99 |
| Spread/Res. | -4.92% | -12.72% | -12.21% |
| Spread/Supp. | +0.72% | +4.41% | +10.32% |
| Support | 20.91 | 20.17 | 19.09 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- EXEL Stock
- Charts Exelixis, Inc.
